MetaADEDB 2.0 @ LMMD
Ezetimibe
(OLNTVTPDXPETLC-XPWALMASSA-N)
Structure
SMILES
Oc1ccc(cc1)[C@@H]1[C@@H](CC[C@@H](c2ccc(cc2)F)O)C(=O)N1c1ccc(cc1)F
Type(s)
Approved
ATC code(s)
C10AX09; C10BA02; C10BA05; C10BA06
Molecular Formula:
C24H21F2NO3
Molecular Weight:
409.425
Log P:
4.9533
Hydrogen Bond Acceptor:
4
Hydrogen Bond Donor:
2
TPSA:
60.77
CAS Number(s):
163222-33-1
Synonym(s)
1.
Ezetimibe
2.
(1-(4-fluorophenyl)-(3R)-(3-(4-fluorophenyl)-(3S)-hydroxypropyl)-(4S)-(4-hydroxyphenyl)-2-azetidinone)
3.
Ezetimib
4.
Ezetrol
5.
SCH 58235
6.
SCH-58235
7.
SCH58235
8.
Zetia
9.
58235, SCH
External Link(s)
MeSHD000069438
PubChem Compound150311
BindingDB50371521
ChEBI49040
CHEMBLCHEMBL1138
DrugBankDB00973
DrugCentral1125
IUPHAR/BPS Guide to PHARMACOLOGY6816
KEGGdr:D01966
Therapeutic Target DatabaseD09LWS
ZINC3810860
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1MyalgiaFAERS: 554
Canada Vigilance: 19
Canada Vigilance
SIDER
US FAERS
2Blood creatine phosphokinase increasedFAERS: 168
Canada Vigilance: 13
Canada Vigilance
OFFSIDES
SIDER
US FAERS
3ArthralgiaFAERS: 167
Canada Vigilance: 7
Canada Vigilance
SIDER
US FAERS
4FatigueFAERS: 164
Canada Vigilance: 4
Canada Vigilance
OFFSIDES
SIDER
US FAERS
5DizzinessFAERS: 127
Canada Vigilance: 10
Canada Vigilance
OFFSIDES
SIDER
US FAERS
6HeadacheFAERS: 123
Canada Vigilance: 5
19167588CTD
SIDER
Canada Vigilance
US FAERS
7PainFAERS: 119
Canada Vigilance: 6
19167588CTD
OFFSIDES
SIDER
Canada Vigilance
US FAERS
8NauseaFAERS: 110
Canada Vigilance: 7
Canada Vigilance
OFFSIDES
SIDER
US FAERS
9Back PainFAERS: 104
Canada Vigilance: 6
Canada Vigilance
SIDER
US FAERS
10PancreatitisFAERS: 102
Canada Vigilance: 7
Canada Vigilance
OFFSIDES
SIDER
US FAERS
11Drug ineffectiveFAERS: 97
Canada Vigilance: 23
Canada Vigilance
US FAERS
12AstheniaFAERS: 92
Canada Vigilance: 5
Canada Vigilance
OFFSIDES
SIDER
US FAERS
13RhabdomyolysisFAERS: 89
Canada Vigilance: 6
18653432CTD
OFFSIDES
SIDER
Canada Vigilance
US FAERS
14Adverse eventFAERS: 77
Canada Vigilance: 3
Canada Vigilance
US FAERS
15Abdominal PainFAERS: 71
Canada Vigilance: 9
Canada Vigilance
OFFSIDES
SIDER
US FAERS
16No adverse eventFAERS: 68US FAERS
17MalaiseFAERS: 65
Canada Vigilance: 7
Canada Vigilance
SIDER
US FAERS
18Abdominal discomfortFAERS: 63
Canada Vigilance: 6
Canada Vigilance
OFFSIDES
US FAERS
19AlopeciaFAERS: 58
Canada Vigilance: 3
Canada Vigilance
OFFSIDES
SIDER
US FAERS
20Chest PainFAERS: 53
Canada Vigilance: 4
Canada Vigilance
OFFSIDES
SIDER
US FAERS
21PruritusFAERS: 53
Canada Vigilance: 5
Canada Vigilance
SIDER
US FAERS
22Drug dose omissionFAERS: 51US FAERS
23Blood cholesterol increasedFAERS: 49
Canada Vigilance: 4
Canada Vigilance
US FAERS
24Myocardial InfarctionFAERS: 46
Canada Vigilance: 5
Canada Vigilance
US FAERS
25Feeling abnormalFAERS: 43
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
SIDER
US FAERS
26ConstipationFAERS: 42
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
27FlatulenceFAERS: 42
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
SIDER
US FAERS
28MyopathyFAERS: 42
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
29HypersensitivityFAERS: 40
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
30Alanine Aminotransferase IncreasedFAERS: 38
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
SIDER
US FAERS
31Aspartate Aminotransferase IncreasedFAERS: 37
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
32UrticariaFAERS: 36
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
33VomitingFAERS: 35
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
34Weight decreasedFAERS: 35
Canada Vigilance: 1
Canada Vigilance
US FAERS
35DyspepsiaFAERS: 34SIDER
US FAERS
36Muscle CrampFAERS: 31US FAERS
37CholelithiasisFAERS: 30
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
38Cerebrovascular accidentFAERS: 29
Canada Vigilance: 3
Canada Vigilance
US FAERS
39Medication ErrorFAERS: 28US FAERS
40Low density lipoprotein increasedFAERS: 25
Canada Vigilance: 7
Canada Vigilance
US FAERS
41Musculoskeletal PainFAERS: 24
Canada Vigilance: 1
Canada Vigilance
US FAERS
42Product quality issueFAERS: 24US FAERS
43Blood triglycerides increasedFAERS: 23OFFSIDES
US FAERS
44Chest discomfortFAERS: 23US FAERS
45TremorFAERS: 23
Canada Vigilance: 1
Canada Vigilance
US FAERS
46Musculoskeletal stiffnessFAERS: 21OFFSIDES
US FAERS
47ErythemaFAERS: 19
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
SIDER
US FAERS
48Inappropriate schedule of drug administrationFAERS: 19US FAERS
49PalpitationsFAERS: 19SIDER
US FAERS
50Neck PainFAERS: 17
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
51AbasiaFAERS: 16US FAERS
52AmnesiaFAERS: 16
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
SIDER
US FAERS
53Angina PectorisFAERS: 16
Canada Vigilance: 1
Canada Vigilance
US FAERS
54TinnitusFAERS: 16OFFSIDES
US FAERS
55AnxietyFAERS: 15OFFSIDES
US FAERS
56Blood creatinine increasedFAERS: 15
Canada Vigilance: 2
Canada Vigilance
US FAERS
57SinusitisFAERS: 15
Canada Vigilance: 1
19167588CTD
SIDER
Canada Vigilance
US FAERS
58SomnolenceFAERS: 15US FAERS
59ArthritisFAERS: 14
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
SIDER
US FAERS
60Atrial FibrillationFAERS: 14
Canada Vigilance: 3
Canada Vigilance
US FAERS
61HepatitisFAERS: 14
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
SIDER
US FAERS
62Joint swellingFAERS: 14US FAERS
63Product dose omissionFAERS: 14
Canada Vigilance: 3
Canada Vigilance
US FAERS
64Blood alkaline phosphatase increasedFAERS: 13SIDER
US FAERS
65Burning sensationFAERS: 13US FAERS
66ChillsFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
67DeafnessFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
68PneumoniaFAERS: 13
Canada Vigilance: 3
Canada Vigilance
US FAERS
69Bone painFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
70Limb discomfortFAERS: 12US FAERS
71MyositisFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
72Anaphylactic shockFAERS: 11SIDER
US FAERS
73Blood lactate dehydrogenase increasedFAERS: 11US FAERS
74ChromaturiaFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
75DysgeusiaFAERS: 11US FAERS
76FlushingFAERS: 11SIDER
US FAERS
77OverdoseFAERS: 11US FAERS
78Product physical issueFAERS: 11US FAERS
79ThrombocytopeniaFAERS: 11SIDER
US FAERS
80Visual ImpairmentFAERS: 11
Canada Vigilance: 2
Canada Vigilance
US FAERS
81Wrong technique in drug usage processFAERS: 11US FAERS
82Activities of daily living impairedFAERS: 10US FAERS
83Drug administration errorFAERS: 10US FAERS
84VertigoFAERS: 10US FAERS
85CholecystitisFAERS: 9SIDER
US FAERS
86CryingFAERS: 9US FAERS
87EpistaxisFAERS: 9
Canada Vigilance: 2
Canada Vigilance
US FAERS
88Gamma-Glutamyltransferase IncreasedFAERS: 9SIDER
US FAERS
89Gastrointestinal PainFAERS: 9
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
90GoutFAERS: 9US FAERS
91Impaired work abilityFAERS: 9US FAERS
92LethargyFAERS: 9OFFSIDES
US FAERS
93Lip swellingFAERS: 9
Canada Vigilance: 3
Canada Vigilance
US FAERS
94Muscle tightnessFAERS: 9US FAERS
95Peripheral swellingFAERS: 9
Canada Vigilance: 3
Canada Vigilance
US FAERS
96Quality of life decreasedFAERS: 9US FAERS
97SwellingFAERS: 9US FAERS
98ToothacheFAERS: 9US FAERS
99Wrong technique in product usage processFAERS: 9US FAERS
100jaundiceFAERS: 9SIDER
US FAERS
101ArthropathyFAERS: 8US FAERS
102BronchitisFAERS: 8
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
103Memory impairmentFAERS: 8
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
104Oropharyngeal painFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
105Prescribed overdoseFAERS: 8US FAERS
106Product substitution issueFAERS: 8
Canada Vigilance: 12
Canada Vigilance
US FAERS
107Product use issueFAERS: 8US FAERS
108nervous system disorderFAERS: 8SIDER
US FAERS
109DehydrationFAERS: 7OFFSIDES
US FAERS
110Diabetes MellitusFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
111DisorientationFAERS: 7US FAERS
112DysarthriaFAERS: 7US FAERS
113DysphoniaFAERS: 7
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
US FAERS
114Erythema MultiformeFAERS: 7
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
115FibromyalgiaFAERS: 7OFFSIDES
US FAERS
116InfluenzaFAERS: 7
Canada Vigilance: 4
Canada Vigilance
SIDER
US FAERS
117Muscle enzyme increasedFAERS: 7US FAERS
118NervousnessFAERS: 7US FAERS
119Pancreatic carcinomaFAERS: 7US FAERS
120Poor quality sleepFAERS: 7
Canada Vigilance: 2
Canada Vigilance
US FAERS
121Psychiatric symptomFAERS: 7US FAERS
122Transaminases increasedFAERS: 7SIDER
US FAERS
123Back disorderFAERS: 6US FAERS
124Blood glucose increasedFAERS: 6US FAERS
125Circumstance or information capable of leading to medication errorFAERS: 6US FAERS
126Erectile dysfunctionFAERS: 6OFFSIDES
SIDER
US FAERS
127GastritisFAERS: 6SIDER
US FAERS
128Intestinal ObstructionFAERS: 6US FAERS
129Mental impairmentFAERS: 6US FAERS
130Middle insomniaFAERS: 6
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
131Musculoskeletal discomfortFAERS: 6SIDER
US FAERS
132Nephrotic SyndromeFAERS: 6US FAERS
133Pharmaceutical product complaintFAERS: 6US FAERS
134SyncopeFAERS: 6US FAERS
135Therapy non-responderFAERS: 6US FAERS
136muscle injuryFAERS: 6US FAERS
137Amyotrophic Lateral SclerosisFAERS: 5US FAERS
138AngioedemaFAERS: 5
Canada Vigilance: 4
Canada Vigilance
OFFSIDES
SIDER
US FAERS
139Blood pressure fluctuationFAERS: 5US FAERS
140DiscomfortFAERS: 5SIDER
US FAERS
141EosinophiliaFAERS: 5SIDER
US FAERS
142EructationFAERS: 5US FAERS
143Erythema NodosumFAERS: 5US FAERS
144Inability to afford medicationFAERS: 5US FAERS
145Incorrect dose administeredFAERS: 5US FAERS
146InfectionFAERS: 5
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
147InflammationFAERS: 5SIDER
US FAERS
148Irritable Bowel SyndromeFAERS: 5US FAERS
149Lichen PlanusFAERS: 5US FAERS
150NasopharyngitisFAERS: 5
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
151Product packaging quantity issueFAERS: 5US FAERS
152Respiratory FailureFAERS: 5
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
153Throat irritationFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
154ThrombosisFAERS: 5US FAERS
155VasculitisFAERS: 5
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
156AgeusiaFAERS: 4OFFSIDES
US FAERS
157AsthmaFAERS: 4
Canada Vigilance: 3
Canada Vigilance
US FAERS
158BradycardiaFAERS: 4US FAERS
159ChokingFAERS: 4US FAERS
160DementiaFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
161DiverticulitisFAERS: 4US FAERS
162Drug effect incompleteFAERS: 4US FAERS
163Dry skinFAERS: 4OFFSIDES
US FAERS
164EczemaFAERS: 4US FAERS
165FrustrationFAERS: 4US FAERS
166General physical health deteriorationFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
167HypotensionFAERS: 4US FAERS
168Impaired driving abilityFAERS: 4US FAERS
169PancytopeniaFAERS: 4US FAERS
170Rash erythematousFAERS: 4US FAERS
171TachycardiaFAERS: 4US FAERS
172Unevaluable eventFAERS: 4OFFSIDES
US FAERS
173Urinary RetentionFAERS: 4US FAERS
174Urinary tract infectionFAERS: 4US FAERS
175VasospasmFAERS: 4US FAERS
176Walking aid userFAERS: 4US FAERS
177AbscessFAERS: 3US FAERS
178Acute myocardial infarctionFAERS: 3OFFSIDES
US FAERS
179AgitationFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
180Amaurosis FugaxFAERS: 3US FAERS
181AnorexiaFAERS: 3US FAERS
182AphasiaFAERS: 3US FAERS
183Blood cholesterol abnormalFAERS: 3OFFSIDES
US FAERS
184Blood creatine phosphokinaseFAERS: 3US FAERS
185Blood glucose abnormalFAERS: 3US FAERS
186Blood potassium decreasedFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
187Cerebral InfarctionFAERS: 3US FAERS
188Coronary Artery DiseaseFAERS: 317666579
19915217
CTD
US FAERS
189CystitisFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
190DisabilityFAERS: 3US FAERS
191Drug prescribing errorFAERS: 3US FAERS
192DysuriaFAERS: 3OFFSIDES
US FAERS
193Emotional distressFAERS: 3OFFSIDES
US FAERS
194Feeling ColdFAERS: 3US FAERS
195Flank PainFAERS: 3OFFSIDES
US FAERS
196Gait inabilityFAERS: 3US FAERS
197GlossitisFAERS: 3US FAERS
198Hepatitis CFAERS: 3US FAERS
199HypersomniaFAERS: 3US FAERS
200Incorrect route of drug administrationFAERS: 3US FAERS
201Joint stiffnessFAERS: 3US FAERS
202Lipase increasedFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
203LymphadenopathyFAERS: 3US FAERS
204Mental status changesFAERS: 3OFFSIDES
US FAERS
205Migraine with AuraFAERS: 3US FAERS
206Muscle FatigueFAERS: 3US FAERS
207Oropharyngeal swellingFAERS: 3US FAERS
208Pain of skinFAERS: 3US FAERS
209Pharyngolaryngeal PainFAERS: 3OFFSIDES
US FAERS
210Prescribed underdoseFAERS: 3US FAERS
211Product packaging issueFAERS: 3US FAERS
212Renal painFAERS: 3US FAERS
213Restless Legs SyndromeFAERS: 3US FAERS
214RestlessnessFAERS: 3US FAERS
215RetchingFAERS: 3US FAERS
216Rheumatoid ArthritisFAERS: 3US FAERS
217RhinitisFAERS: 3US FAERS
218StressFAERS: 3
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
219Thrombocytopenic purpuraFAERS: 3US FAERS
220Unexpected therapeutic drug effectFAERS: 3US FAERS
221Ventricular FibrillationFAERS: 3US FAERS
222Vitamin D DeficiencyFAERS: 3US FAERS
223Aldolase increasedFAERS: 2US FAERS
224Altered state of consciousnessFAERS: 2US FAERS
225Anal discomfortFAERS: 2US FAERS
226AneurysmFAERS: 2US FAERS
227AngerFAERS: 2US FAERS
228AnhedoniaFAERS: 2US FAERS
229Ankle FractureFAERS: 2US FAERS
230Anorectal discomfortFAERS: 2US FAERS
231AnosmiaFAERS: 2US FAERS
232AphoniaFAERS: 2US FAERS
233ArteriosclerosisFAERS: 2OFFSIDES
US FAERS
234Autoimmune thrombocytopeniaFAERS: 2US FAERS
235BlindnessFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
236Blood amylase increasedFAERS: 2OFFSIDES
US FAERS
237Blood blisterFAERS: 2US FAERS
238Blood glucose decreasedFAERS: 2OFFSIDES
US FAERS
239Blood potassium increasedFAERS: 2OFFSIDES
US FAERS
240Blood urea increasedFAERS: 2US FAERS
241BruxismFAERS: 2US FAERS
242Cardiac FlutterFAERS: 2US FAERS
243Carpal Tunnel SyndromeFAERS: 2US FAERS
244CataractFAERS: 2OFFSIDES
US FAERS
245CholestasisFAERS: 2US FAERS
246ColitisFAERS: 2US FAERS
247Cubital Tunnel SyndromeFAERS: 2US FAERS
248Cytolytic hepatitisFAERS: 2US FAERS
249Depressed Level of ConsciousnessFAERS: 2US FAERS
250Diabetes mellitus inadequate controlFAERS: 2US FAERS
251DiplopiaFAERS: 2US FAERS
252Drug exposure during pregnancyFAERS: 2US FAERS
253DuodenitisFAERS: 2US FAERS
254DysgraphiaFAERS: 2US FAERS
255Ear discomfortFAERS: 2US FAERS
256Emotional disorderFAERS: 2US FAERS
257Enzyme level abnormalFAERS: 2US FAERS
258EpilepsyFAERS: 2US FAERS
259Eye irritationFAERS: 2US FAERS
260Eye painFAERS: 2
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
261FasciitisFAERS: 2US FAERS
262FormicationFAERS: 2OFFSIDES
US FAERS
263Gallbladder painFAERS: 2US FAERS
264Gastrointestinal motility disorderFAERS: 2US FAERS
265Guillain-Barre SyndromeFAERS: 2US FAERS
266Head discomfortFAERS: 2US FAERS
267Hepatic congestionFAERS: 2US FAERS
268High density lipoprotein increasedFAERS: 2US FAERS
269HoarsenessFAERS: 2US FAERS
270HyperthyroidismFAERS: 2US FAERS
271HypophagiaFAERS: 2US FAERS
272HypothyroidismFAERS: 2US FAERS
273IleusFAERS: 2US FAERS
274Initial insomniaFAERS: 2OFFSIDES
US FAERS
275Keratoconjunctivitis SiccaFAERS: 2US FAERS
276Leukocytoclastic vasculitisFAERS: 2US FAERS
277Macular degenerationFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
278MalabsorptionFAERS: 2US FAERS
279MonoplegiaFAERS: 2US FAERS
280Mood swingsFAERS: 2US FAERS
281Mouth swellingFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
282Multiple SclerosisFAERS: 2US FAERS
283MutismFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
284Myasthenia GravisFAERS: 2OFFSIDES
US FAERS
285Nasal discomfortFAERS: 2OFFSIDES
US FAERS
286NeuralgiaFAERS: 2OFFSIDES
US FAERS
287NeuropathyFAERS: 2US FAERS
288Night sweatsFAERS: 2US FAERS
289No adverse effectFAERS: 2US FAERS
290NoduleFAERS: 2US FAERS
291Non-cardiac chest painFAERS: 2US FAERS
292Oral painFAERS: 2US FAERS
293OverweightFAERS: 2US FAERS
294Pancreatic enzymes increasedFAERS: 2US FAERS
295PharyngitisFAERS: 2SIDER
US FAERS
296PlagueFAERS: 2US FAERS
297Product distribution issueFAERS: 2US FAERS
298Product supply issueFAERS: 2US FAERS
299Product use in unapproved indicationFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
300Productive CoughFAERS: 2
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
301Pulmonary EmbolismFAERS: 2US FAERS
302Pulmonary congestionFAERS: 2US FAERS
303PyelonephritisFAERS: 2US FAERS
304Renal tubular necrosisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
305RosaceaFAERS: 2US FAERS
306ScreamingFAERS: 2US FAERS
307Shoulder PainFAERS: 2US FAERS
308Skin UlcerFAERS: 2US FAERS
309Skin irritationFAERS: 2US FAERS
310Skin lesionFAERS: 2OFFSIDES
US FAERS
311Skin reactionFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
312Skin tightnessFAERS: 2US FAERS
313SneezingFAERS: 2US FAERS
314SomnambulismFAERS: 2US FAERS
315Squamous cell carcinomaFAERS: 2US FAERS
316Stevens-Johnson SyndromeFAERS: 2OFFSIDES
US FAERS
317StomatitisFAERS: 2US FAERS
318Subcutaneous AbscessFAERS: 2US FAERS
319Sudden deathFAERS: 2US FAERS
320TachyarrhythmiaFAERS: 2US FAERS
321Tooth ExtractionFAERS: 2US FAERS
322Toxicity to various agentsFAERS: 2US FAERS
323UlcerFAERS: 2US FAERS
324Visual disturbanceFAERS: 2OFFSIDES
US FAERS
325Abdominal adhesionsFAERS: 1US FAERS
326Abdominal massFAERS: 1OFFSIDES
US FAERS
327Abdominal symptomFAERS: 1US FAERS
328Abdominal tendernessFAERS: 1US FAERS
329Accidental deathFAERS: 1OFFSIDES
US FAERS
330Accidental overdoseFAERS: 1US FAERS
331Accidental underdoseFAERS: 1US FAERS
332Acquired diaphragmatic eventrationFAERS: 1US FAERS
333Acute kidney injuryFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
334Adenoid Cystic CarcinomaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
335Alanine aminotransferase abnormalFAERS: 1US FAERS
336Allergic respiratory symptomFAERS: 1US FAERS
337Ammonia increasedFAERS: 1US FAERS
338Amylase increasedFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
339Aortic AneurysmFAERS: 1OFFSIDES
US FAERS
340Aphthous StomatitisFAERS: 1US FAERS
341Aquagenic pruritusFAERS: 1US FAERS
342AscitesFAERS: 1US FAERS
343Aspartate aminotransferase normalFAERS: 1US FAERS
344Atrioventricular BlockFAERS: 1US FAERS
345Autoimmune thyroiditisFAERS: 1US FAERS
346Benign Prostatic HyperplasiaFAERS: 1US FAERS
347Bilirubin conjugated increasedFAERS: 1US FAERS
348Bladder NeoplasmFAERS: 1US FAERS
349Bladder discomfortFAERS: 1OFFSIDES
US FAERS
350Blood albumin decreasedFAERS: 1US FAERS
351Blood alkaline phosphatase abnormalFAERS: 1US FAERS
352Blood bilirubin abnormalFAERS: 1US FAERS
353Blood cholesterol normalFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
354Blood count abnormalFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
355Blood creatine increasedFAERS: 1US FAERS
356Blood creatine phosphokinase MB increasedFAERS: 1US FAERS
357Blood creatine phosphokinase decreasedFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
358Blood iron decreasedFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
359Blood magnesium abnormalFAERS: 1US FAERS
360Blood pressure immeasurableFAERS: 1US FAERS
361Blood testosterone decreasedFAERS: 1US FAERS
362Blood thyroid stimulating hormone increasedFAERS: 1US FAERS
363Blood urine presentFAERS: 1US FAERS
364Blood zinc decreasedFAERS: 1US FAERS
365Bone density decreasedFAERS: 1US FAERS
366BradykinesiaFAERS: 1US FAERS
367BradyphreniaFAERS: 1US FAERS
368Breast tendernessFAERS: 1US FAERS
369Carcinoembryonic antigen increasedFAERS: 1US FAERS
370Cardiac ArrestFAERS: 1US FAERS
371Cardiac ablationFAERS: 1US FAERS
372Cardiac enzymes increasedFAERS: 1US FAERS
373CellulitisFAERS: 1OFFSIDES
US FAERS
374Cerebral disorderFAERS: 1US FAERS
375CheilitisFAERS: 1US FAERS
376Chest wall painFAERS: 1US FAERS
377Choking sensationFAERS: 1US FAERS
378Cholecystitis infectiveFAERS: 1OFFSIDES
US FAERS
379CholecystostomyFAERS: 1US FAERS
380CholelithotomyFAERS: 1US FAERS
381Chronic sinusitisFAERS: 1US FAERS
382Cold sweatFAERS: 1US FAERS
383Colon adenomaFAERS: 1US FAERS
384Completed SuicideFAERS: 1US FAERS
385ConjunctivitisFAERS: 1US FAERS
386CyanosisFAERS: 1US FAERS
387CystFAERS: 1US FAERS
388Dark circles under eyesFAERS: 1US FAERS
389Deafness NeurosensoryFAERS: 1US FAERS
390DeliriumFAERS: 1US FAERS
391Dental discomfortFAERS: 1US FAERS
392Depressed moodFAERS: 1US FAERS
393Drug ToleranceFAERS: 1US FAERS
394Drug dispensing errorFAERS: 1US FAERS
395Drug interaction inhibitionFAERS: 1US FAERS
396Drug withdrawal syndromeFAERS: 1US FAERS
397Duodenal UlcerFAERS: 1US FAERS
398DyscheziaFAERS: 1US FAERS
399Eating disorder symptomFAERS: 1US FAERS
400Economic problemFAERS: 1OFFSIDES
US FAERS
401Ejection fraction abnormalFAERS: 1US FAERS
402Electrocardiogram ST segment abnormalFAERS: 1US FAERS
403Enzyme level increasedFAERS: 1US FAERS
404Epigastric discomfortFAERS: 1US FAERS
405ErysipelasFAERS: 1US FAERS
406Fear of fallingFAERS: 1US FAERS
407Feeling jitteryFAERS: 1US FAERS
408Feeling of body temperature changeFAERS: 1US FAERS
409Fibromuscular DysplasiaFAERS: 1US FAERS
410Food PoisoningFAERS: 1US FAERS
411Foreign body sensation in eyesFAERS: 1US FAERS
412Gastric pH decreasedFAERS: 1US FAERS
413Gastric ulcerFAERS: 1OFFSIDES
US FAERS
414GastroenteritisFAERS: 1US FAERS
415GastrostomyFAERS: 1US FAERS
416Genital rashFAERS: 1US FAERS
417Genital swellingFAERS: 1US FAERS
418Gingival HyperplasiaFAERS: 1US FAERS
419Grip strength decreasedFAERS: 1US FAERS
420Heart sounds abnormalFAERS: 1US FAERS
421Heart valve stenosisFAERS: 1US FAERS
422HemiparesisFAERS: 1US FAERS
423Hepatitis EFAERS: 1US FAERS
424HepatotoxicityFAERS: 1OFFSIDES
US FAERS
425HerniaFAERS: 1OFFSIDES
US FAERS
426HypertransaminasaemiaFAERS: 1US FAERS
427HypertrichosisFAERS: 1OFFSIDES
US FAERS
428Hypoaesthesia facialFAERS: 1US FAERS
429HypotrichosisFAERS: 1US FAERS
430HypoventilationFAERS: 1US FAERS
431Iatrogenic injuryFAERS: 1US FAERS
432Immune thrombocytopenic purpuraFAERS: 1US FAERS
433Implantable defibrillator insertionFAERS: 1US FAERS
434Incorrect product storageFAERS: 1US FAERS
435Increased tendency to bruiseFAERS: 1US FAERS
436Increased upper airway secretionFAERS: 1US FAERS
437IndurationFAERS: 1US FAERS
438Injection Site ReactionFAERS: 1US FAERS
439Intestinal PerforationFAERS: 1US FAERS
440IritisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
441Joint Range of Motion DecreasedFAERS: 1US FAERS
442Joint warmthFAERS: 1US FAERS
443Lactose IntoleranceFAERS: 1US FAERS
444LaryngitisFAERS: 1US FAERS
445LaryngospasmFAERS: 1US FAERS
446LeukopeniaFAERS: 1US FAERS
447LichenificationFAERS: 1US FAERS
448Lip and/or oral cavity cancerFAERS: 1US FAERS
449Lipids abnormalFAERS: 1US FAERS
450LipomatosisFAERS: 1US FAERS
451Lower respiratory tract infectionFAERS: 1US FAERS
452Lyme DiseaseFAERS: 1US FAERS
453LymphomaFAERS: 1US FAERS
454MalnutritionFAERS: 1SIDER
US FAERS
455MastitisFAERS: 1US FAERS
456Maternal exposure before pregnancyFAERS: 1US FAERS
457Mechanical ileusFAERS: 1US FAERS
458Meniscus injuryFAERS: 1US FAERS
459Mental FatigueFAERS: 1US FAERS
460Metabolic myopathyFAERS: 1US FAERS
461Metastases to thoraxFAERS: 1US FAERS
462Mixed liver injuryFAERS: 1US FAERS
463MoaningFAERS: 1US FAERS
464Multiple MyelomaFAERS: 1US FAERS
465Muscle RigidityFAERS: 1US FAERS
466Muscle SpasticityFAERS: 1US FAERS
467Muscle necrosisFAERS: 1US FAERS
468Muscle strainFAERS: 1US FAERS
469Musculoskeletal chest painFAERS: 1OFFSIDES
US FAERS
470MyoclonusFAERS: 1US FAERS
471Myoglobin blood increasedFAERS: 1US FAERS
472Myositis-like syndromeFAERS: 1US FAERS
473Nasal sinus drainageFAERS: 1US FAERS
474NecrosisFAERS: 1US FAERS
475Nephritis allergicFAERS: 1US FAERS
476NephrolithiasisFAERS: 1US FAERS
477NeuritisFAERS: 1US FAERS
478NocturiaFAERS: 1US FAERS
479Nonspecific reactionFAERS: 1US FAERS
480Nuchal RigidityFAERS: 1US FAERS
481Obesity surgeryFAERS: 1US FAERS
482ObesityFAERS: 1US FAERS
483ObstructionFAERS: 1US FAERS
484Ocular icterusFAERS: 1US FAERS
485OliguriaFAERS: 1US FAERS
486Oral candidiasisFAERS: 1US FAERS
487Oral mucosal erythemaFAERS: 1US FAERS
488Oropharyngeal plaqueFAERS: 1US FAERS
489OsteoporosisFAERS: 1US FAERS
490Otitis MediaFAERS: 1US FAERS
491PallorFAERS: 1US FAERS
492Pancreatic CystFAERS: 1US FAERS
493Pancreatic InsufficiencyFAERS: 1US FAERS
494Pancreatic NeoplasmFAERS: 1US FAERS
495Pancreatic duct dilatationFAERS: 1US FAERS
496Paranasal sinus discomfortFAERS: 1US FAERS
497Paranasal sinus hypersecretionFAERS: 1US FAERS
498Partner stressFAERS: 1US FAERS
499Patient dissatisfaction with treatmentFAERS: 1US FAERS
500Pericardial effusionFAERS: 1US FAERS
501PericarditisFAERS: 1US FAERS
502Peripheral arterial occlusive diseaseFAERS: 1US FAERS
503Personality change due to a general medical conditionFAERS: 1US FAERS
504PetechiaeFAERS: 1US FAERS
505PhlebitisFAERS: 1US FAERS
506Physical product label issueFAERS: 1US FAERS
507Pityriasis RoseaFAERS: 1US FAERS
508Pneumatosis intestinalisFAERS: 1US FAERS
509PolyarthritisFAERS: 1US FAERS
510PolydipsiaFAERS: 1US FAERS
511PolymyositisFAERS: 1US FAERS
512PolyneuropathyFAERS: 1US FAERS
513PolyuriaFAERS: 1US FAERS
514Poor peripheral circulationFAERS: 1US FAERS
515Poor quality drug administeredFAERS: 1US FAERS
516Porphyria non-acuteFAERS: 1US FAERS
517PresyncopeFAERS: 1US FAERS
518Product contamination physicalFAERS: 1US FAERS
519Product difficult to swallowFAERS: 1US FAERS
520Product label issueFAERS: 1US FAERS
521Prostatic dysplasiaFAERS: 1US FAERS
522ProstatismFAERS: 1US FAERS
523Protein total decreasedFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
524Pruritus AniFAERS: 1US FAERS
525Pulmonary FibrosisFAERS: 1US FAERS
526QuadriparesisFAERS: 1US FAERS
527Rash scalyFAERS: 1US FAERS
528Reaction to drug excipientsFAERS: 1US FAERS
529Rectal tenesmusFAERS: 1US FAERS
530Reflux gastritisFAERS: 1US FAERS
531Respiratory ParalysisFAERS: 1US FAERS
532Respiratory distressFAERS: 1US FAERS
533Restrictive pulmonary diseaseFAERS: 1US FAERS
534Retinal Artery OcclusionFAERS: 1US FAERS
535Rotator cuff syndromeFAERS: 1US FAERS
536SciaticaFAERS: 1US FAERS
537Seasonal Affective DisorderFAERS: 1US FAERS
538Secretion dischargeFAERS: 1US FAERS
539SepsisFAERS: 1US FAERS
540Septic ShockFAERS: 1US FAERS
541Serum SicknessFAERS: 1US FAERS
542Sexual DysfunctionFAERS: 1US FAERS
543Sick relativeFAERS: 1US FAERS
544Similar reaction on previous exposure to drugFAERS: 1US FAERS
545Sinus headacheFAERS: 1US FAERS
546Sinus operationFAERS: 1US FAERS
547Sinus painFAERS: 1US FAERS
548Skin hypertrophyFAERS: 1US FAERS
549Sleep TalkingFAERS: 1US FAERS
550Sleep disorder due to general medical condition, insomnia typeFAERS: 1US FAERS
551SluggishnessFAERS: 1US FAERS
552Spinal column stenosisFAERS: 1US FAERS
553StaringFAERS: 1US FAERS
554StrabismusFAERS: 1US FAERS
555Swallow study abnormalFAERS: 1US FAERS
556Synovial CystFAERS: 1US FAERS
557SynovitisFAERS: 1US FAERS
558Systemic lupus erythematosus rashFAERS: 1US FAERS
559Systemic mycosisFAERS: 1US FAERS
560TetanyFAERS: 1US FAERS
561Therapeutic response unexpectedFAERS: 1US FAERS
562Therapy cessationFAERS: 1US FAERS
563Therapy regimen changedFAERS: 1US FAERS
564Thyroid cancer metastaticFAERS: 1US FAERS
565Tongue erythemaFAERS: 1US FAERS
566Tongue exfoliationFAERS: 1US FAERS
567Toxic Epidermal NecrolysisFAERS: 1US FAERS
568Trigeminal Nerve DisorderFAERS: 1US FAERS
569Unresponsive to stimuliFAERS: 1OFFSIDES
US FAERS
570Upper respiratory tract infection bacterialFAERS: 1US FAERS
571Upper-airway cough syndromeFAERS: 1US FAERS
572Urinary IncontinenceFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
573UveitisFAERS: 1US FAERS
574Vascular ruptureFAERS: 1US FAERS
575Visual acuity reduced transientlyFAERS: 1US FAERS
576Vitamin B6 increasedFAERS: 1US FAERS
577Vitamin K DeficiencyFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
578Vitreous floatersFAERS: 1US FAERS
579Wheelchair userFAERS: 1US FAERS
580Wrong drug administeredFAERS: 1US FAERS
581angiogramFAERS: 1US FAERS
582cancer surgeryFAERS: 1US FAERS
583prostatitisFAERS: 1US FAERS
584Abdominal wall cystOFFSIDES
585Acid refluxOFFSIDES
586AdenocarcinomaOFFSIDES
587Air EmbolismOFFSIDES
588AlveolitisOFFSIDES
589Anticonvulsant drug level above therapeuticOFFSIDES
590Antidepressant drug level above therapeuticOFFSIDES
591Antipsychotic drug level increasedOFFSIDES
592Antiviral drug level above therapeuticOFFSIDES
593ApathyOFFSIDES
594Application site erythemaOFFSIDES
595Application site scabOFFSIDES
596AtaxiaOFFSIDES
597AtelectasisOFFSIDES
598Atherosclerosis20399059CTD
599Bacterial conjunctivitisOFFSIDES
600Bipolar DisorderOFFSIDES
601Bipolar I disorderOFFSIDES
602BlepharoptosisOFFSIDES
603Blood 1,25-dihydroxycholecalciferol decreasedOFFSIDES
604Blood GlucoseOFFSIDES
605Blood and lymphatic system disordersSIDER
606Blood cholesterolOFFSIDES
607Blood glucose fluctuationOFFSIDES
608Blood phosphorus increasedOFFSIDES
609Blood sodium increasedOFFSIDES
610Blood thrombin abnormalOFFSIDES
611Blood thyroid stimulating hormoneOFFSIDES
612Blurred visionOFFSIDES
613CD4 Lymphocytes DecreasedOFFSIDES
614Carbon Monoxide PoisoningOFFSIDES
615Cataract operationOFFSIDES
616Cerebrovascular accident prophylaxisOFFSIDES
617Chemical and Drug Induced Liver Injury24014644CTD
618Chemotherapeutic drug level increasedOFFSIDES
619CholangiolitisOFFSIDES
620Chronic Fatigue SyndromeOFFSIDES
621Chronic respiratory failureOFFSIDES
622ClaustrophobiaOFFSIDES
623Clostridium difficile colitisOFFSIDES
624ColectomyOFFSIDES
625Color blindnessOFFSIDES
626ConfabulationOFFSIDES
627Conjunctival depositOFFSIDES
628Creatine Phosphokinase IncreasedSIDER
629Dehydroepiandrosterone increasedOFFSIDES
630Dehydroepiandrosterone testOFFSIDES
631DemyelinationOFFSIDES
632DermatitisSIDER
633DermatomyositisCanada Vigilance: 1Canada Vigilance
SIDER
634Device malfunctionOFFSIDES
635DiabetesOFFSIDES
636Diabetic ulcerOFFSIDES
637DiarrheaOFFSIDES
638Difficult to wean from ventilatorOFFSIDES
639Disease complicationCanada Vigilance: 1Canada Vigilance
640DrowsinessOFFSIDES
641Dyslipidemias

View details

CTD
642Ejection Fraction DecreasedOFFSIDES
643Electrocardiogram poor R-wave progressionOFFSIDES
644Electrocardiogram repolarisation abnormalityOFFSIDES
645EncephalitisOFFSIDES
646Enterococcal infectionOFFSIDES
647Enterovesical FistulaOFFSIDES
648Enzyme abnormalityOFFSIDES
649Erosive gastritisOFFSIDES
650Eye InfectionOFFSIDES
651Factor V inhibitionOFFSIDES
652Gallop rhythm presentOFFSIDES
653GamblingOFFSIDES
654GangreneOFFSIDES
655Gastric infectionOFFSIDES
656GiardiasisOFFSIDES
657Gingival pruritusOFFSIDES
658GlaucomaCanada Vigilance: 1Canada Vigilance
659GranulocytosisOFFSIDES
660GranulomaOFFSIDES
661Heparin-induced thrombocytopeniaOFFSIDES
662Hepatic necrosisOFFSIDES
663Hungry bone syndromeOFFSIDES
664Hypercholesterolemia15374793
17076980
CTD
665Hyperlipidemia, Familial Combined20152243CTD
666Hyperlipoproteinemias20377808CTD
667HyperparathyroidismOFFSIDES
668Hypersensitive syndromeSIDER
669Hypertensive emergencyOFFSIDES
670Hypertriglyceridemia18420099
20377808
CTD
671Hypoalphalipoproteinemias20152243CTD
672Hypothalamo-pituitary disorderOFFSIDES
673HypoxiaOFFSIDES
674InfestationSIDER
675Injection site noduleOFFSIDES
676Intervertebral disc injuryOFFSIDES
677Kidney FailureOFFSIDES
678Left atrial dilatationOFFSIDES
679Lens dislocationCanada Vigilance: 1Canada Vigilance
680Limb injuryCanada Vigilance: 1Canada Vigilance
681LipaseOFFSIDES
682Lupus-like syndromeSIDER
683Malignant HypertensionOFFSIDES
684Medical device complicationOFFSIDES
685Memory LossSIDER
686Mental disorder due to a general medical conditionOFFSIDES
687MonoparesisCanada Vigilance: 1Canada Vigilance
688Muscle WeaknessOFFSIDES
689Muscle relaxant drug level above therapeuticOFFSIDES
690Musculoskeletal Diseases19167588CTD
691Nasal pruritusCanada Vigilance: 1Canada Vigilance
692Neutropenic colitisOFFSIDES
693OnychoclasisCanada Vigilance: 1Canada Vigilance
694Oral fungal infectionOFFSIDES
695Oral mucosal exfoliationOFFSIDES
696OsteopeniaOFFSIDES
697PanniculitisSIDER
698Peripheral embolismOFFSIDES
699Pharyngeal lesionOFFSIDES
700Polymyalgia RheumaticaSIDER
701Postoperative ileusOFFSIDES
702Potentiating drug interactionOFFSIDES
703Proteinuria19666118CTD
704PseudoporphyriaOFFSIDES
705Respiratory Tract Infections19167588CTD
706Retinal vascular thrombosisOFFSIDES
707Schizoaffective DisorderOFFSIDES
708Serum serotonin decreasedOFFSIDES
709Sexual relationship changeOFFSIDES
710Sick Sinus SyndromeOFFSIDES
711Sitosterolemia19428931CTD
712Spinal StenosisCanada Vigilance: 1Canada Vigilance
713Sputum culture positiveOFFSIDES
714Subclavian artery thrombosisOFFSIDES
715Sudden Cardiac DeathOFFSIDES
716Superficial ThrombophlebitisOFFSIDES
717Supraventricular tachycardiaOFFSIDES
718Temperature intoleranceOFFSIDES
719Temporal ArteritisOFFSIDES
720TonsillitisOFFSIDES
721Tooth InfectionOFFSIDES
722Tracheal painOFFSIDES
723Troponin I increasedOFFSIDES
724Urine arsenic increasedOFFSIDES
725Urine flow decreasedOFFSIDES
726Viral myocarditisCanada Vigilance: 1Canada Vigilance
727Viral test positiveCanada Vigilance: 1Canada Vigilance
728VitrectomyOFFSIDES
729Vitreous DetachmentCanada Vigilance: 1Canada Vigilance
730Vulvovaginal mycotic infectionOFFSIDES
731Weight GainOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.